You are here

BİR OLGU NEDENİYLE ANTIGLOMERUL BAZAL MEMBRAN HASTALIĞI

Journal Name:

Publication Year:

Abstract (2. Language): 
Antiglomerıtlar basal membrane disease: A case report. AntiglomeruSar basement membrane (AGBM) disease or Goodpasture's syndrome is an autoimmune disorder in whiclı lungs and kidneys are effected. Its incidence is 0.5 per nıillion. Male adulls are mainly affected by this disorder with unknown etiology. A case of rapidly proggressive renal insufficiency requiring hemodialysis trcatment, whose pulmonary signs and symptoms relieved only after intravenous gammaglobulinc treatment; though shc was treated earlier vvith cyclophosphamide and stero-ids wilhout any response, is herein reported
Abstract (Original Language): 
Antiği om erül bazal membran (AGBM) hastalığı ya da Goodpasture sendromu, insidansı milyonda 0.5 olan, böbrek ve akciğer tutulumu ile seyreden otoimmun bir hastalıktır. Etyolojisi çok iyi bilinmeyen bu tablo çoğu kez erişkin erkeklerde gözlenir. Burada hızlı ilerleyen glo-merülonefrit tablosu ile başvuran ve hemodiyalize alınan; immunosiipresif tedavi olarak sİklo-fosfamid vc sleroid kullanmasına rağmen akciğer semptomları ancak intravenöz gammaglobu-lin tedavisi sonrasında düzelen bir olgu sunuldu
188-191

REFERENCES

References: 

1. Ang C, Savige J, Dawborn J, Miach P, Heaİe W, Ciarkc B, Sinclair RS: Anti-glomerülar basement membrane (GBM)-antibody-mediiitetl disease with normal renal function. Nephrol Dial Transplant 13:935 (1998).
2. Bal! JA, Young KR: Pulmonary manifestations of Goodpasture's syndrome. AntiglomerülaT basement disease and relatcd disorders. Clin CheslMed 19:777 (1998).
3. Daimon S, Umeda T, Michishita I, VVakasugi H, Genda A, Koni i: Goodpalure's-üke syndrome and effect of exl-racorporeal membrane oxygenator support. Jntern Med 33:569 (1994).
4. Flores JC, Savage COS, Lockwood CM, Taube D, Cameron JS, Williams DG, Ogg CS: Clinical and immunologjcal evolution of olîgoanııric anti-gbm nephrîüs trealed by haemodialysis. Lancet i:5 (1986).
5. Groggeİ GC, Terrcros DA: Role of the terminal comple-mentpathway in acceleraLcd aııtologous anti-glomerular basement membrane nephritis. AJP 136:533 (1990).
6. Johnson JP, Whitman W, Briggs WA: Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome. Am S Med 64:354(1978).
7. Kovİthavoags T, Dossctor IB: Goodpasture's syndrome with normal renal function. Nephrol Diai Transplant 12:1540(1997).
8. Merkel F, Pullig O, Marx M, Nelzer KO, Weber M: Co-urse and prognosis of anti-basement membrane anlibody (anti-BM-Ab)-mediaced disease: report of 35 cases. Nephrol Diai Transplant 9:372 (1994).
9. Niles JL, Böttmgcr EP, Saurina GR, Kelly O, Pan G, Coliins AB, McCluskey RT: The syndrome of lııng he-morrage and nephritis is usually an ANCA associated condition. Arch intem Med 156:440 (1996).
10. Sanchez-Fructuoso Al, Blanco J, Naranjo P, Prats D, Barrientos A: Antiglomerular basement membrane antihody-mcdiated nephritis in two patients wilh type II diabetes mcllitus Nephrol Dial Transplant 13:2674 (1998).
11. Strııfelt G, Mousa F, Jonsson H, Nived O, Thysell H, WoUheim F: Recurrent cerebral infaıction and the anlip-lıosphoîipid syndrome: effect of intravenotıs gammaglo-bulin in a patient with systemic lupus eryîhemalosus. Ann Rheum Dis 49: 939 (1990).
12. Westman KWA, Bygren PG, Eilert I, Wiik A, Wieslan-der J: Rapid sereening assay for anti-GBM antibody and ANCAs; an important tool for the differentiai dİagnosis of pulmonary renal syndromes. Nephrol Dial Transplant 12:1863 (1997).

Thank you for copying data from http://www.arastirmax.com